No abstract available
MeSH terms
-
Aged
-
Antibodies, Monoclonal, Humanized / adverse effects*
-
Antineoplastic Agents, Immunological / adverse effects*
-
Drug Therapy, Combination
-
Humans
-
Lymphohistiocytosis, Hemophagocytic / chemically induced
-
Lymphohistiocytosis, Hemophagocytic / drug therapy*
-
Male
-
Prostatic Neoplasms / drug therapy
-
Steroids / therapeutic use*
-
Tacrolimus / therapeutic use*
-
Treatment Outcome
Substances
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents, Immunological
-
Steroids
-
pembrolizumab
-
Tacrolimus